机译:日本转移性肾细胞癌患者阳光尼血浆血浆浓度与临床结果的关系
Tohoku Univ Hosp Dept Pharmaceut Sci Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Grad Sch Med Dept Urol Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Hosp Dept Pharmaceut Sci Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Hosp Dept Pharmaceut Sci Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Hosp Dept Pharmaceut Sci Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Hosp Dept Pharmaceut Sci Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Hosp Dept Pharmaceut Sci Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Grad Sch Med Dept Urol Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Grad Sch Med Dept Urol Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Sendai Med Ctr Dept Urol Miyagino Ku 2-6-8 Miyagino Sendai Miyagi 8938520 Japan;
Tohoku Univ Grad Sch Med Dept Urol Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Hosp Dept Pharmaceut Sci Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Grad Sch Med Dept Urol Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Tohoku Univ Hosp Dept Pharmaceut Sci Aoba Ku 1-1 Seiryo Machi Sendai Miyagi 9808574 Japan;
Renal cell carcinoma; Tyrosine kinase inhibitor; Sunitinib; Pharmacokinetics; Therapeutic drug monitoring;
机译:日本转移性肾细胞癌患者阳光尼血浆血浆浓度与临床结果的关系
机译:日本转移性肾细胞癌患者依维莫司血药浓度与临床结局的长期关系:一项前瞻性研究
机译:舒尼替尼治疗透明细胞转移性肾细胞癌的临床疗效和血浆血管生成标志物
机译:何时治疗转移性肾细胞癌的组合,全身治疗,以及在转移性肾癌中的活跃监测
机译:用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
机译:苹果酸舒尼替尼和N-去乙基-舒尼替尼血浆浓度的药代动力学对转移性肾细胞癌患者治疗效果的临床意义
机译:MP16-01 Sunitinib和N-脱乙基 - Sunitinib血浆浓度治疗转移肾细胞癌患者治疗结果的临床意义